your partner in preclinical research
2016 v2

Season's Greetings and Best Wishes!

Best wishes from UROSPHERE for a great year 2016 !

Discover our greeting card !

Read more
Header 1

Let urosphereestablish the preclinical proof of concept for your drug candidates.

Header 3

A new era is beginning for UROSPHERE.

We extend our activities to GASTROENTEROLOGY and ONCOLOGY.

Header 2

UROsphere becomes urosphere+

logotype-vector_corporate-H

 

Your partner in preclinical research

UROSPHERE is a leading Contract Research Organization specializing in preclinical urogenital, gastro-intestinal and oncological pharmacology assays. We provide the pharmaceutical and biopharmaceutical industries with a unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues.

Learn more about us

News & eventS

Events // News & Events // Jan 27 2016

UROSPHERE will attend the toulouse oncoweek, to be held in toulouse, france, february...

We will have an oral communication on "Optical imaging in preclinical tumour models: helpful or pitfall?”

Read more

News // News & Events // Jan 22 2016

UROSPHERE and Ambiotis sign a strategic collaboration agreement

UROSPHERE and Ambiotis another Contract Research Organization, based in Toulouse, France announce a strategic partnership to broaden and strenghten their respective activities. Under...

Read more

News // News & Events // Jan 08 2016

Season's Greetings and Best Wishes!

Best wishes from UROSPHERE for a great year 2016 !

Read more

News // News & Events // Jun 30 2015

UROSPHERE ANNOUNCES ISO 9001 CERTIFICATION.

Urosphere is pleased to announce another step in its commitment to the highest quality standards. Urosphere obtained the certification of its Quality Management System (QMS) ISO 9001:...

Read more

News // Mar 10 2015

ORGANOCAN : UROsphere collaborative project.

Colorectal cancers and those of the urological sphere (prostate and bladder) are among the five most common cancers. A chronic inflammatory condition predisposes to the appearance of some...

Read more
All news

Publications

Oncology // Publications // Jan 19 2016

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen...

Legrier ME, Bièche I, Gaston J, Beurdeley A, Yvonnet V, Déas O, Thuleau A, Château-Joubert S, Servely JL, Vacher S, Lassalle M, Depil S, C Tucker G, Fontaine JJ, Poupon MF, Roman-Roman...

Read more

Gastroenterology // Publications // Nov 15 2015

Apelin targets gut contraction to control glucose metabolism via the brain

Fournel A, Drougard A, Duparc T, Marlin A, Brierley S, Le-Gonidec S, Masri B, Colom A, Lucas A, Rousset P, Cenac N, Vergnolle N, Valet P, Cani P, Knauf C
Gut., 2015

Read more

Publications // Urology // May 27 2015

Differences in the contractility of human isolated prostatic urethra to oxytocin...

McCallum S, Collegeville PA, Rouget C, Rekik M, Camparo P, Botto H, Rischmann P, Lluel P, Palea S, Westfall T.

The Journal of Urology. 193:356, 2015

Read more

Nephrology // Publications // Jun 15 2014

Effect of tadalafil in a rat model of renal ischemia-reperfusion injury

Chiara Alfarano, Maria-Alba Guardia, Philippe Lluel and Stefano Palea.

Nephrol. Dial. Transplant. 29, 2014

Read more

Publications // Urology // Jun 14 2014

Comparison of the effects of ß3-adrenoceptor agonism on urinary bladder function...

J.B. Beauval, V. Guilloteau, M. Cappellini, T.D. Westfall, P. Rischmann, S. Palea, X. Gamé, P. Lluel.

Neurourol Urodyn. 34: 155-160, 2014

Read more
All publications